{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:09:01Z","timestamp":1793938141069,"version":"4.8.0"},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2025,8,6]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>The 2025 update of the Association of British Neurologists guidelines for the management of autoimmune myasthenia gravis (MG) emphasises several points that are distinct from the 2015 guidelines based on recent research and publications. The main differences from the previous guidelines are: (1) The recommendation to prescribe daily steroids rather than the alternate day regimen is now standard practice. (2) There is a clear emphasis on the beneficial effects of early thymectomy. (3) Randomised controlled trial evidence now supports early use of rituximab (within 1 year of generalised disease onset), although the evidence is less robust, but still likely to be useful, in established treatment-refractory MG. (4) Finally, several clinical trials have been published for newer targeted therapies in MG, predominantly those that inhibit the complement and neonatal Fc gamma receptor pathways, the roles of which are being slowly established especially in patients unresponsive to conventional therapy.<\/jats:p>","DOI":"10.1136\/pn-2025-004655","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:00:15Z","timestamp":1757703615000},"page":"422-437","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)"],"prefix":"10.1136","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-454X","authenticated-orcid":false,"given":"Saiju","family":"Jacob","sequence":"first","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"},{"name":"Department of Neurology, University Hospitals Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Farrugia","sequence":"additional","affiliation":[{"name":"Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channa","family":"Hewamadduma","sequence":"additional","affiliation":[{"name":"Academic Neuromuscular Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"Sheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Norwood","sequence":"additional","affiliation":[{"name":"Department of Neurology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Hill","sequence":"additional","affiliation":[{"name":"Neurology, Swansea Bay University Health Board, Port Talbot, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Paul","family":"McConville","sequence":"additional","affiliation":[{"name":"Department of Neurology, Queens University, Belfast and South East Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-9600","authenticated-orcid":false,"given":"Ashwin Arnold","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wessex Neurological Centre, Southampton General Hospital, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Spillane","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, London, UK"},{"name":"Department of Neurology, Guys and St Thomas\u2019 NHS Foundation Trust, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Sussman","sequence":"additional","affiliation":[{"name":"Neurology, Salford Royal NHS Foundation Trust, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Viegas","sequence":"additional","affiliation":[{"name":"Neurology, Imperial College Healthcare NHS Trust, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"2025091212001208000_25.5.422.1","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2015-001126"},{"key":"2025091212001208000_25.5.422.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.193912"},{"key":"2025091212001208000_25.5.422.3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cen3.12739","article-title":"The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert\u2013Eaton myasthenic syndrome","volume":"14","author":"Murai","year":"2023","journal-title":"Clinical & Exp Neuroim"},{"key":"2025091212001208000_25.5.422.4","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231213240","article-title":"Guideline for the management of myasthenic syndromes","volume":"16","author":"Wiendl","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"2025091212001208000_25.5.422.5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s13760-024-02552-7","article-title":"Recommendations for the management of myasthenia gravis in Belgium","volume":"124","author":"De Bleecker","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"2025091212001208000_25.5.422.6","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41433-024-03133-x","article-title":"Treating myasthenia gravis beyond the eye clinic","volume":"38","author":"Jacob","year":"2024","journal-title":"Eye (Lond)"},{"key":"2025091212001208000_25.5.422.7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/0004-282x-anp-2022-s105","article-title":"Myasthenia gravis in clinical practice","volume":"80","author":"Estephan","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"2025091212001208000_25.5.422.8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"key":"2025091212001208000_25.5.422.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.01.011"},{"key":"2025091212001208000_25.5.422.10","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1139"},{"key":"2025091212001208000_25.5.422.11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jocn.2023.04.011","article-title":"Single count breath test for the evaluation of respiratory function in Myasthenia Gravis: A systematic review","volume":"112","author":"Dishnica","year":"2023","journal-title":"J Clin Neurosci"},{"key":"2025091212001208000_25.5.422.12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24929"},{"key":"2025091212001208000_25.5.422.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602489"},{"key":"2025091212001208000_25.5.422.14","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2023-003708"},{"key":"2025091212001208000_25.5.422.15","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2023-003855"},{"key":"2025091212001208000_25.5.422.16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2022.2887","article-title":"Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial","volume":"79","author":"Piehl","year":"2022","journal-title":"JAMA Neurol"},{"key":"2025091212001208000_25.5.422.17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1404191","article-title":"Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis","volume":"15","author":"Cavalcante","year":"2024","journal-title":"Front Immunol"},{"key":"2025091212001208000_25.5.422.18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/ITT.S377056","article-title":"Novel Immunotherapies for Myasthenia Gravis","volume":"12","author":"Nair","year":"2023","journal-title":"Immunotargets Ther"},{"key":"2025091212001208000_25.5.422.19","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16180","article-title":"Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy","volume":"31","author":"Sacc\u00e0","year":"2024","journal-title":"Eur J Neurol"},{"key":"2025091212001208000_25.5.422.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305572"},{"key":"2025091212001208000_25.5.422.21","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1093\/brain\/awad153","article-title":"The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD)","volume":"146","author":"Allen","year":"2023","journal-title":"Brain"},{"key":"2025091212001208000_25.5.422.22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.nmd.2021.04.002","article-title":"Prevalence and associated factors of fatigue in autoimmune myasthenia gravis","volume":"31","author":"Ruiter","year":"2021","journal-title":"Neuromuscul Disord"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2025-004655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:00:32Z","timestamp":1757703632000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2025-004655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/pn-2025-004655"],"URL":"https:\/\/doi.org\/10.1136\/pn-2025-004655","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}